Therapeutic intervention with sivelestat, a selective neutrophil elastase inhibitor [79], effectively preserved EMILIN-1 integrity and restored lymphatic function, demonstrating a significant reduction in lymphedema. The gene discussed is EMILIN1; the disease is lymphedema.